Dimension Therapeutics to develop gene therapy treatments for patients with Ornithine Transcarbamylase deficiency and Glycogen Storage Disease Type Ia
23 April 2015 | By Victoria White
Dimension Therapeutics is advancing programmes to treat two rare diseases with often devastating outcomes for patients - OTC deficiency and GSDIa...